| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/20/2000 | WO2000042201A2 Human peptidases |
| 07/20/2000 | WO2000042192A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | WO2000042191A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/20/2000 | WO2000042188A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | WO2000042181A1 Minor histocompatibility antigens and their use in diagnosis and treatment of tumors |
| 07/20/2000 | WO2000042176A1 Selection of monoclonal antibodies |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | WO2000042165A2 Bone marrow-specific protein |
| 07/20/2000 | WO2000042074A1 Anti-ccr4 antibodies and methods of use therefor |
| 07/20/2000 | WO2000042073A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | WO2000042072A2 Polypeptide variants with altered effector function |
| 07/20/2000 | WO2000042070A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | WO2000042069A1 Bone stimulating factor |
| 07/20/2000 | WO2000042068A2 Hiv related peptides |
| 07/20/2000 | WO2000042064A1 Peptides for inhibiting hpv e6 proteins |
| 07/20/2000 | WO2000042063A2 Peptides for inhibiting hbv core proteins |
| 07/20/2000 | WO2000041724A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | WO2000041722A1 Use of antibodies for anticancer vaccination |
| 07/20/2000 | WO2000041721A1 Process for purifying immunoglobulins |
| 07/20/2000 | WO2000041516A2 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | WO2000041508A2 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines |
| 07/20/2000 | WO2000041474A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | WO2000031141B1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 07/20/2000 | WO2000020590A3 G-protein coupled receptor proteins |
| 07/20/2000 | WO2000020041A3 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 07/20/2000 | WO2000017235A3 Cytokine receptor zalpha11 |
| 07/20/2000 | WO2000015772A3 Recombinant protein production in urine |
| 07/20/2000 | WO2000015250A3 Fibroblast inhibitor |
| 07/20/2000 | WO2000004149A3 Compositions and methods for therapy and diagnosis of prostate cancer |
| 07/20/2000 | WO2000002902A9 Novel inhibitors of angiogenesis and tumor growth |
| 07/20/2000 | WO2000002897A9 Delta cleavage products and methods based thereon |
| 07/20/2000 | WO1999054353A3 Human nucleic acid sequences of normal uterus tissue |
| 07/20/2000 | DE19901009A1 Peptide zur Inhibierung von HBV-Core-Proteinen Peptides to inhibit HBV core proteins |
| 07/20/2000 | DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins |
| 07/20/2000 | CA2361204A1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2360584A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | CA2360464A1 Human peptidases |
| 07/20/2000 | CA2359504A1 Novel compounds |
| 07/20/2000 | CA2359486A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | CA2359132A1 Bone marrow-specific protein |
| 07/20/2000 | CA2359067A1 Polypeptide variants with altered effector function |
| 07/20/2000 | CA2358908A1 Bone stimulating factor |
| 07/20/2000 | CA2358748A1 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | CA2358693A1 Anti-ccr4 antibodies and methods of use therefor |
| 07/20/2000 | CA2358684A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | CA2356939A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/19/2000 | EP1020522A1 Natural human antibody |
| 07/19/2000 | EP1020519A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| 07/19/2000 | EP1020516A2 Leptospira vaccine antigens for the prevention of leptospirosis |
| 07/19/2000 | EP1019542A1 Methods to modulate blood pressure and diagnose bartter's syndrome type iii |
| 07/19/2000 | EP1019514A1 A keratinocyte derived protease |
| 07/19/2000 | EP1019513A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases |
| 07/19/2000 | EP1019510A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 07/19/2000 | EP1019508A1 Tnf-related death ligand |
| 07/19/2000 | EP1019506A1 101 human secreted proteins |
| 07/19/2000 | EP1019504A1 Isoforms of the human vitamin d receptor |
| 07/19/2000 | EP1019503A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 07/19/2000 | EP1019502A2 Human orphan receptor ntr-1 |
| 07/19/2000 | EP1019500A2 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/19/2000 | EP1019442A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 07/19/2000 | EP1019441A2 ANTI-BiP-ANTIBODIES IN RHEUMATOID ARTHRITIS, METHOD AND TEST KITS FOR DETECTING THEM |
| 07/19/2000 | EP1019439A1 Soluble single-chain t-cell receptor proteins |
| 07/19/2000 | EP1019438A1 Apoptosis-related compounds and their use |
| 07/19/2000 | EP1019436A1 Acquired resistance npr genes and uses thereof |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019423A2 Method for producing a pentopyranosyl nucleoside |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019095A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019086A1 Altered dna synthesome components as biomarkers for malignancy |
| 07/19/2000 | EP1019085A1 Non-anaphylactic forms of allergens and their use |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019068A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | CN1260834A Antimicrobial peptide |
| 07/19/2000 | CN1260833A LAG-3 splice variants |
| 07/19/2000 | CN1054609C Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor |
| 07/18/2000 | US6091001 Genetically engineered rodent embryonic stem cell capable of expressing immunoglobulins; for producing adjusted immunoglobulins with changed antigen preferentials |
| 07/18/2000 | US6090930 Recombinant human anti-FB5 antibodies |
| 07/18/2000 | US6090924 Human-Human CLNH5-specific antibodies |
| 07/18/2000 | US6090923 Immunoglobulin that preferentially binds a human cytotoxin; for the treatment of virus infected or tumor target cells |
| 07/18/2000 | US6090922 Imunoglobulin that binds mammalian adhesive protein |
| 07/18/2000 | US6090920 Aminoterminal propeptides of typed 1 procollagen |
| 07/18/2000 | US6090918 Polypeptide associated with the inhibition of prostaglandin biosynthesis and treating inflammation |
| 07/18/2000 | US6090914 CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
| 07/18/2000 | US6090789 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof |
| 07/18/2000 | US6090621 Monoclonal antibody that binds specifically to hydrolyase enzyme; for treatment of calcium signaling, phosphatidylinositol and inositol polyphosphate defects; gene therapy; antiproliferative agents |
| 07/18/2000 | US6090620 Genes and gene products related to Werner's syndrome |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090587 Prokaryotic expression of MHC proteins |
| 07/18/2000 | US6090586 66 kDa antigen from Borrelia |
| 07/18/2000 | US6090583 Expression system in compatible host cell of a polynucleotide which produces a metalloprotease; diagnosis and treatment of asthma, disorders of leukotriene metabolism; anticarcinogenic agents; antiinflammatory/antidiabetic/antiarthritic agents |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090578 Composition comprising at least 75% w/w of human multiple tumor suppressor 1 polypeptide; diagnosis of predisposition for cancer; anticarcinogenic agents; gene therapy |